Moreover, a dysregulation of the renin–angiotensin–aldosterone system (RAAS) has been documented in patients with MASLD, which plays a role in the development of hypertension, hypertension-mediated organ damage, increased vascular resistance, and cardiac remodeling [184]. Here, REN is linked to hypertensive disorder.